ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02210221
Previous Study | Return to List | Next Study

CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02210221
Recruitment Status : Completed
First Posted : August 6, 2014
Last Update Posted : March 20, 2018
Sponsor:
Collaborators:
University of Cambridge
Erasmus Medical Center
San Gerardo Hospital
University of Sheffield
University of California, San Francisco
Karolinska Institutet
ICON plc
GABO:mi
icoMetrix NV, Leuven, Belgium
Information provided by (Responsible Party):
Andrew Maas, University Hospital, Antwerp

Brief Summary:

The research aims of the CENTER-TBI study are to:

  1. better characterize Traumatic Brain Injury (TBI) as a disease and describe it in a European context, and
  2. identify the most effective clinical interventions for managing TBI.

Specific aims

  1. To collect high quality clinical and epidemiological data with repositories for neuro-imaging, DNA, and serum from patients with TBI.
  2. To refine and improve outcome assessment and develop health utility indices for TBI.
  3. To develop multidimensional approaches to characterisation and prediction of TBI.
  4. To define patient profiles which predict efficacy of specific interventions ("Precision Medicine").
  5. To develop performance indicators for quality assurance and quality improvement in TBI care.
  6. To validate the common data elements (CDEs) for broader use in international settings, and to develop a user-friendly web based data entry instrument and case report form builder.
  7. To develop an open database compatible with Federal Interagency Traumatic Brain Injury Research (FITBIR).
  8. To intensify networking activities and international collaborations in TBI.
  9. To disseminate study results and management recommendations for TBI to health care professionals, policy makers and consumers, aiming to improve health care for TBI at individual and population levels.
  10. To develop a "knowledge commons" for TBI, integrating CENTER-TBI outputs into systematic reviews.

Condition or disease
Traumatic Brain Injury

  Show Detailed Description

Study Type : Observational [Patient Registry]
Actual Enrollment : 5742 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Months
Official Title: Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)
Actual Study Start Date : October 2014
Actual Primary Completion Date : December 1, 2017
Study Completion Date : March 30, 2020



Primary Outcome Measures :
  1. Glasgow Outcome Scale - Extended (GOSE) [ Time Frame: 6 months ]

    Cross-sectional analyses will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  2. SF-12v2 Health Survey (Short-Form Health Survey with 12 questions) [ Time Frame: 6 months ]

    Cross-sectional analyses will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will permit additional evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  3. Quality of Life in Brain Injury Questionnaire Overall Scale (QOLIBRI-OS) [ Time Frame: 6 months ]

    Cross-sectional analyses will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;


Secondary Outcome Measures :
  1. Quality of Life in Brain Injury Questionnaire (QOLIBRI) [ Time Frame: 6 months ]

    Evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Timepoints per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  2. The Post-traumatic Stress Disorder (PTSD) Checklist for DSM-5 (PCL-5) [ Time Frame: 6 months ]

    Evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  3. Rivermead Post Concussion Questionnaire [ Time Frame: 6 months ]

    Evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  4. SF-36v2 Health Survey (Short-Form Health Survey with 36 questions) [ Time Frame: 6 months ]

    Evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 3 months, 6 months, 12 months, and 24 months;
    • ICU stratum: 3 months, 6 months, 12 months and 24 months;

  5. Galveston Orientation and Amnesia Test (GOAT) [ Time Frame: 6 months ]

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury.This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  6. Rey Auditory Verbal Learning Test (RAVLT) [ Time Frame: 6 months ]

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  7. Trail Making Test (TMT) [ Time Frame: 6 months ]

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  8. Cambridge Neuropsychological Test Automated Battery (CANTAB) [ Time Frame: 6 months ]

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  9. 10 meter walk and timed up and go test [ Time Frame: 6 months ]

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  10. JK Coma Recovery Scale - Revised [ Time Frame: 6 months ]

    Condition: in untestable patients only (GOAT<66)

    A pre-specified neuropsychological evaluation will be performed in all strata (ER stratum, Admission stratum and ICU stratum) at 6 months after injury and longitudinal at various time points in the three strata up to 24 months after injury. This will additionally permit evaluation of changes over time.

    Time points per stratum:

    • ER stratum: 2-3 weeks, 3 months and 6 months;
    • Admission stratum: 6 months, 12 months, and 24 months;
    • ICU stratum: 6 months, 12 months and 24 months;

  11. MRI imaging [ Time Frame: Between 2-3 weeks after enrolment ]

    Centre's participating in the MR data collection arm will undertake MR scans of the brain locally, using a 3 Tesla scanning, some sites will also undertake ultra-early MR scans (<72 hours post TBI).

    The imaging protocols will be standardized as much as possible and central quality control of uploaded images will be performed by Icometrix. Standardization between centers will be further enhanced by the use of phantoms and by studying nine healthy control subjects per site.

    MRI time points per stratum:

    ER stratum

    • 200 patients: within 72 hours
    • 600 patients: 2-3 weeks
    • 250 patients: 3 months

    Admission stratum

    • 200 patients: <72 hours
    • 600 patients: 2-3 weeks
    • 600 patients: 6 months
    • 300 patients: 12 months
    • 150 patients: 24 months

    ICU stratum

    • 200 patients: <72 hours
    • 600 patients: 2-3 weeks
    • 600 patients: 6 months
    • 300 patients: 12 months
    • 150 patients: 24 months


Biospecimen Retention:   Samples With DNA
whole blood samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients presenting with traumatic brain injury.

The data collection will be stratified upon enrolment into 3 clinical groups differentiated by clinical care path:

  • ER stratum: patients seen and discharged from the ER
  • Admission stratum: patients admitted to hospital but not to the ICU
  • ICU stratum: patients admitted directly to the ICU
Criteria

Inclusion Criteria:

  • Clinical diagnosis of TBI
  • Clinical indication for CT scan
  • Presentation within 24 hours of injury
  • Informed consent obtained according to local and national requirements

Exclusion Criteria:

  • Severe pre-existing neurological disorder that would confound outcome assessments

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02210221


  Show 65 Study Locations
Sponsors and Collaborators
University Hospital, Antwerp
University of Cambridge
Erasmus Medical Center
San Gerardo Hospital
University of Sheffield
University of California, San Francisco
Karolinska Institutet
ICON plc
GABO:mi
icoMetrix NV, Leuven, Belgium
Investigators
Study Chair: Andrew Maas, MD, PhD Antwerp University Hospital / University of Antwerp, Edegem, Belgium
Study Director: David Menon, MD, PhD University of Cambridge, Addenbrookes hospital, Cambridge, UK

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Andrew Maas, M.D., PhD, Project Coordinator CENTER-TBI, University Hospital, Antwerp
ClinicalTrials.gov Identifier: NCT02210221     History of Changes
Other Study ID Numbers: 602150
First Posted: August 6, 2014    Key Record Dates
Last Update Posted: March 20, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Keywords provided by Andrew Maas, University Hospital, Antwerp:
TBI

Additional relevant MeSH terms:
Brain Injuries
Brain Injuries, Traumatic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries